Pneumocystis elicits a STAT6-dependent, strain-specific innate immune response and airway hyperresponsiveness

Steve D Swain1, Nicole N Meissner, Dan W Siemsen

  • 1Department of Immunology and Infectious Diseases, Montana State University, Bozeman, MT 59717, USA. uvsss@montana.edu

Insights

Fungal exposure, like Pneumocystis, can cause lung damage and airway hyperresponsiveness (AHR) in susceptible mice. This early innate immune response is strain-specific and linked to STAT6 signaling.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Pathology

Background:

  • Fungal exposure is linked to comorbidities like asthma and COPD.
  • While allergic responses to fungi are studied, early innate immune responses and pathology remain underexplored.

Purpose of the Study:

  • To investigate early innate immunological responses and pathology to Pneumocystis fungal exposure.
  • To analyze strain-specific differences in lung damage and airway hyperresponsiveness (AHR).

Main Methods:

  • Examined early immune responses and pathology in BALB/c and C57BL/6 mice after Pneumocystis exposure.
  • Assessed lung damage markers (albumin, LDH) and AHR.
  • Investigated the role of STAT6 signaling and specific immune cells (neutrophils, NK, NKT, CD4 T cells) and cytokines (IFN-γ, IL-4).

Main Results:

  • BALB/c mice showed a strong, strain-specific early response with immune cell recruitment, lung damage, and profound AHR.
  • C57BL/6 mice lacked this early response but cleared Pneumocystis later.
  • AHR and inflammation were largely absent without STAT6 signaling.
  • Gene expression suggested involvement of transcription factors in pulmonary remodeling.

Conclusions:

  • Early innate immune responses to fungi like Pneumocystis can cause lung pathology and AHR.
  • Genetic background and STAT6 signaling significantly influence these responses.
  • Fungal exposure can contribute to morbidity even without prior sensitization.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...